Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RoboDesign International was a specialized technology company that developed automated systems for the life sciences, specifically focusing on protein crystallography and high-throughput screening. The company's flagship product, the CrystalMation system, provided a fully integrated environment for protein crystallization, from plate preparation to image analysis. By automating these complex processes, RoboDesign helped pharmaceutical and academic researchers accelerate structural biology studies and drug discovery. The company was acquired by Rigaku in 2003, integrating its automation expertise into Rigaku's X-ray diffraction product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RoboDesign International.